Simple view

Full metadata view

Authors

Statistics

Choroba endomiokardialna jako pierwsza manifestacja zespołu hipereozynofilowego

2010
journal article
article
Journal
Kardiologia Polska = Polish Heart Journal
Alternative title

Endomyocardial disease as the first manifestation of hypereosinophilic syndrome

Author
Poręba Małgorzata

Rostoff Paweł

Konduracka Ewa

Pikul Patrycja

Rucińska Małgorzata
Show more
Volume
68
Number
4
Pages
440-445
ISSN
0022-9032
eISSN
1897-4279
Keywords in English

hypereosinophilic syndrome

eosinophilia

endomyocardial disease

URL
https://www.mp.pl/kardiologiapolska/en/node/13153/pdf
Access date
2020-08-17
Remarks

Bibliogr. s. 445

Language
Polish
Journal language
English
Abstract in English

A case of hypereosinophilic syndrome (HES) initially manifesting as endomyocardial disease in a 21-year-old man is presented. The diagnosis of HES was made according to the Chusid’s criteria. Myeloproliferative disorders were excluded and corticosteroid therapy with prednisone at a dose of 1 mg/kg/d was started immediately. After 30 days of continuous corticotherapy the patient recovered completely. His blood eosinophil count decreased from 8740 cells/µL (48.7%) to 30 cells/µL (0.3%). Then, prednisone was discontinued gradually. During 18-month follow-up the patient was free from cardiovascular symptoms and his complete blood count was normal. We also present the current state of knowledge on the cardiovascular complications of hypereosinophilic syndrome.

Affiliation
Wydział Lekarski : Instytut Kardiologii
dc.abstract.enA case of hypereosinophilic syndrome (HES) initially manifesting as endomyocardial disease in a 21-year-old man is presented. The diagnosis of HES was made according to the Chusid’s criteria. Myeloproliferative disorders were excluded and corticosteroid therapy with prednisone at a dose of 1 mg/kg/d was started immediately. After 30 days of continuous corticotherapy the patient recovered completely. His blood eosinophil count decreased from 8740 cells/µL (48.7%) to 30 cells/µL (0.3%). Then, prednisone was discontinued gradually. During 18-month follow-up the patient was free from cardiovascular symptoms and his complete blood count was normal. We also present the current state of knowledge on the cardiovascular complications of hypereosinophilic syndrome.pl
dc.affiliationWydział Lekarski : Instytut Kardiologiipl
dc.contributor.authorPoręba, Małgorzatapl
dc.contributor.authorRostoff, Paweł - 301326 pl
dc.contributor.authorKonduracka, Ewa - 130237 pl
dc.contributor.authorPikul, Patrycjapl
dc.contributor.authorRucińska, Małgorzatapl
dc.contributor.authorPasowicz, Mieczysławpl
dc.contributor.authorPiwowarska, Wiesława - 352487 pl
dc.date.accession2020-08-17pl
dc.date.accessioned2020-08-17T08:12:03Z
dc.date.available2020-08-17T08:12:03Z
dc.date.issued2010pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.additionalBibliogr. s. 445pl
dc.description.number4pl
dc.description.physical440-445pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume68pl
dc.identifier.eissn1897-4279pl
dc.identifier.issn0022-9032pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/244128
dc.identifier.weblinkhttps://www.mp.pl/kardiologiapolska/en/node/13153/pdfpl
dc.languagepolpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa*
dc.rights.licenceCC-BY-NC-ND
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl*
dc.share.typeotwarte czasopismo
dc.subject.enhypereosinophilic syndromepl
dc.subject.eneosinophiliapl
dc.subject.enendomyocardial diseasepl
dc.subtypeArticlepl
dc.titleChoroba endomiokardialna jako pierwsza manifestacja zespołu hipereozynofilowegopl
dc.title.alternativeEndomyocardial disease as the first manifestation of hypereosinophilic syndromepl
dc.title.journalKardiologia Polska = Polish Heart Journalpl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.abstract.enpl
A case of hypereosinophilic syndrome (HES) initially manifesting as endomyocardial disease in a 21-year-old man is presented. The diagnosis of HES was made according to the Chusid’s criteria. Myeloproliferative disorders were excluded and corticosteroid therapy with prednisone at a dose of 1 mg/kg/d was started immediately. After 30 days of continuous corticotherapy the patient recovered completely. His blood eosinophil count decreased from 8740 cells/µL (48.7%) to 30 cells/µL (0.3%). Then, prednisone was discontinued gradually. During 18-month follow-up the patient was free from cardiovascular symptoms and his complete blood count was normal. We also present the current state of knowledge on the cardiovascular complications of hypereosinophilic syndrome.
dc.affiliationpl
Wydział Lekarski : Instytut Kardiologii
dc.contributor.authorpl
Poręba, Małgorzata
dc.contributor.authorpl
Rostoff, Paweł - 301326
dc.contributor.authorpl
Konduracka, Ewa - 130237
dc.contributor.authorpl
Pikul, Patrycja
dc.contributor.authorpl
Rucińska, Małgorzata
dc.contributor.authorpl
Pasowicz, Mieczysław
dc.contributor.authorpl
Piwowarska, Wiesława - 352487
dc.date.accessionpl
2020-08-17
dc.date.accessioned
2020-08-17T08:12:03Z
dc.date.available
2020-08-17T08:12:03Z
dc.date.issuedpl
2010
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.additionalpl
Bibliogr. s. 445
dc.description.numberpl
4
dc.description.physicalpl
440-445
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
68
dc.identifier.eissnpl
1897-4279
dc.identifier.issnpl
0022-9032
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/244128
dc.identifier.weblinkpl
https://www.mp.pl/kardiologiapolska/en/node/13153/pdf
dc.languagepl
pol
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa
dc.rights.licence
CC-BY-NC-ND
dc.rights.uri*
http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl
dc.share.type
otwarte czasopismo
dc.subject.enpl
hypereosinophilic syndrome
dc.subject.enpl
eosinophilia
dc.subject.enpl
endomyocardial disease
dc.subtypepl
Article
dc.titlepl
Choroba endomiokardialna jako pierwsza manifestacja zespołu hipereozynofilowego
dc.title.alternativepl
Endomyocardial disease as the first manifestation of hypereosinophilic syndrome
dc.title.journalpl
Kardiologia Polska = Polish Heart Journal
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations
No affiliation
Poręba, Małgorzata
Rostoff, Paweł
Konduracka, Ewa
Pikul, Patrycja
Rucińska, Małgorzata
Pasowicz, Mieczysław
Piwowarska, Wiesława

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Open Access

Thumbnail Image
License
CC-BY-NC-ND

Except as otherwise noted, this item is licensed under : Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa

Collections
ROD UJ
Medical sciences
Research publications